基于中医“扶正祛邪”理论探讨固表止嚏方治疗变应性鼻炎的临床疗效观察
Clinical Efficacy Observation of Gubiao Zhiti Formula for Allergic Rhinitis Based on the Traditional Chinese Medicine Theory of “Supporting the Righteous and Eliminating the Pathogenic”
DOI: 10.12677/acm.2026.1693136, PDF,    科研立项经费支持
作者: 杜晓璇, 吴敏曼*, 毛元尔, 曲比衣作, 邱博文, 周颖云, 刘子豪, 王 慧:云南省中医医院(云南中医药大学第一附属医院),云南 昆明
关键词: 变应性鼻炎;扶正祛邪;固表止嚏汤;Allergic Rhinitis; Supporting the Righteous and Eliminating the Pathogenic; Gubiao Zhiti Formula
摘要: 目的:研究及探讨云南省耳鼻喉科名中医郭兆刚教授经验方固表止嚏方治疗变应性鼻炎的临床疗效。方法:选择我院耳鼻喉科2025年1月~2026年1月就诊的变应性鼻炎患者,将符合纳入标准的72例患者采用随机数字表法分为两组,每组36例。治疗组口服固表止嚏方,对照组给予口服氯雷他定片治疗。两组均连续治疗4周,分别于治疗前后进行临床症状评分,观察临床疗效。结果:治疗组的总有效率为77.78%;而对照组的总有效率为63.89%。P = 0.011差异具有统计学意义(P < 0.05),治疗组的临床疗效优于对照组。结论:固表止嚏方治疗过敏性鼻炎临床疗效显著。
Abstract: Objective: To study and evaluate the clinical efficacy of Gubiao Zhiti Formula, an experience formula by Professor Guo Zhaogang, a renowned TCM physician in otolaryngology from Yunnan Province, for treating allergic rhinitis. Methods: A total of 72 patients diagnosed with allergic rhinitis who visited our hospital’s Department of Otolaryngology between January 2025 and January 2026 were selected and randomly divided into two groups (36 cases each) using a random number table. The treatment group received oral administration of Gubiao Zhiti Formula, while the control group was given loratadine tablets orally. Both groups were treated continuously for four weeks. Clinical symptom scores were assessed before and after treatment to evaluate therapeutic outcomes. Results: The overall effective rate in the treatment group was 77.78%, compared to 63.89% in the control group. The difference was statistically significant (P = 0.011, P < 0.05), indicating superior clinical efficacy in the treatment group. Conclusion: Gubiao Zhiti Formula demonstrates significant clinical effectiveness in treating allergic rhinitis.
文章引用:杜晓璇, 吴敏曼, 毛元尔, 曲比衣作, 邱博文, 周颖云, 刘子豪, 王慧. 基于中医“扶正祛邪”理论探讨固表止嚏方治疗变应性鼻炎的临床疗效观察[J]. 临床医学进展, 2026, 16(9): 1045-1051. https://doi.org/10.12677/acm.2026.1693136

参考文献

[1] Muhamad, S.H.N., Tina, T.H.T., Norasnieda, S.M., et al. (2022) Allergic Rhinitis: A Clinical and Pathophysiological Overview. Frontiers in Medicine, 9, Article ID: 874114.
[2] 韩德民. 上下呼吸道炎症相关性研究[J]. 中国医学文摘-耳鼻咽喉科学, 2006, 21(3): 130-132.
[3] Li, S., Shaker, M. and Peters, A. (2026) Medical Management of Rhinitis: Medication Options. Immunology and Allergy Clinics of North America, 46, 97-109.
https://doi.org/10.1016/j.iac.2025.09.007
[4] 郭兆刚. 固表止嚏汤治疗变态反应性鼻炎87例小结[J]. 云南中医学院学报, 1992, 15(1): 6-7.
[5] 陈建军, 程雷, 等. 中国变应性鼻炎诊断和治疗指南(2022年, 修订版) [J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(2): 106-129.
[6] 杨上善. 黄帝内经太素肖延平校正[M]. 北京: 人民卫生出版社, 1965.
[7] 顾之燕, 韩子刚, 刘志连. 耳鼻咽喉科变应性和免疫性疾病[M]. 天津: 天津卫生出版社, 2000: 11-13.
[8] 田道法. 中西医结合耳鼻咽喉科学[M]. 北京: 中国中医药出版社, 2005.
[9] 王士贞. 中医耳鼻咽喉科临床研究[M]. 北京: 人民卫生出版社, 2009.
[10] Liao, C., Liu, T., Zeng, Z., Wang, D., Tang, G., Wang, H., et al. (2020) Efficacy and Safety of Modified Yupingfeng Formula in Treating Allergic Rhinitis: A Protocol for Systematic Review and Meta-Analysis. Medicine, 99, e23698.
https://doi.org/10.1097/md.0000000000023698
[11] 叶晓滨, 陈玉梅. 玉屏风散的现代药理研究及临床应用研究进展[J]. 光明中医, 2021, 36(8): 1360-1365.
[12] 董晓宜, 王红丽, 韩涛, 等. 基于网络药理学和分子对接探究苍耳子散治疗过敏性鼻炎的作用机制[J]. 现代药物与临床, 2023, 38(1): 58-64.
[13] 梁婉君, 赵惠芳, 黄小刚, 等. 基于网络药理学和分子对接探讨鼻炎数据挖掘核心方苍耳子散作用机制[J]. 中国医药科学, 2023, 13(19): 23-27.